二重HPIV3/RSV融合阻害剤の構造による改善
Victor K Outlaw1, Jennifer T Lemke1, Yun Zhu2,3
1Department of Chemistry , University of Wisconsin , Madison , Wisconsin 53706 , United States.
Journal of the American Chemical Society
|January 18, 2020
まとめ
新しいペプチド誘導体は,ヒトパラインフルエンザウイルス3 (HPIV3) と呼吸器シンシチアルウイルス (RSV) 感染症に対する有効性を高めています. これらの二重抑制剤は融合グリコプロテインを標的とし,これらの一般的な呼吸器疾患の治療に有望な戦略を提供します.
科学分野:
- ウイルス学
- 構造生物学
- 薬物の発見
背景:
- ヒトパラインフルエンザウイルス3 (HPIV3) と呼吸器シンチチアルウイルス (RSV) は重度の呼吸器感染症の主な原因です.
- 現在HPIV3とRSVの治療は限られており,ワクチンや抗ウイルス療法はありません.
研究 の 目的:
- HPIV3とRSV融合グリコプロテインの両方を標的とした新しいペプチド阻害剤の設計と開発.
- 以前に特定された二重抑制剤の効能と安定性を改善する.
主な方法:
- HPIV3融合グリコタンパク質に基づくペプチド阻害剤の構造誘導設計
- VIQKIペプチド配列にフェニララニンの置換を導入する.
- 阻害剤融合タンパク質ドメイン複合体の結晶分析
- HPIV3およびRSV感染に対する有効性を評価する抗ウイルス試験.
主要な成果:
- フェニララニン置換によるVIQKIペプチド誘導体は,HPIV3およびRSVに対する抗ウイルス活性が強化されたことを示した.
- I456FとI454F/I456Fの置換は,ウイルス融合タンパク質領域とのより安定した相互作用をもたらした.
- コクリスタル構造は,強化された結合と抑制に寄与する特定の水性相互作用を明らかにした.
結論:
- VIQKIペプチドの構造による改変は,HPIV3とRSVに対する二重抑制能力を有意に改善します.
- 開発されたフェニララニン置換阻害剤は,HPIV3およびRSV感染と戦うための有望な治療戦略です.
関連する概念動画
01:22Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
01:18Endocarditis III: Medical Management
175
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
175
01:29Endocarditis IV: Nursing Management
266
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
266
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
393
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
393
01:28Pneumonia IV: Management
691
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
691
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
182
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
182